GENI.L LSE
GENinCode plc
1W: -14.3%
1M: -21.1%
3M: -16.7%
YTD: -31.8%
1Y: -46.4%
3Y: -94.0%
5Y: -98.3%
£0.75 ($0.01)
+0.05 (+7.14%)
Weekly Expected Move ±12.9%
£1
£1
£1
£1
£1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
#7
of 7
Medical - Diagnostics & Research
Technical Signal Map
0 Bullish
1 Neutral
6 Bearish
Peer Comparison
| Symbol | Mkt Cap | P/E | ROE % | ROIC % | Net Mgn % | Rev Grw % | Piotroski | Signal | 1Y Ret % |
|---|---|---|---|---|---|---|---|---|---|
| GENI.L GENinCode plc | — | -0.5 | -419.6 | -8421.9 | -223.9 | 27.8 | 4 | BEARISH | -46.4 |
| ABDX.L Abingdon Health Plc | $40M | -13.1 | -143.7 | -152.8 | -55.4 | 116.1 | 5 | NEUTRAL | 92.2 |
| VRCI.L Verici Dx plc | $10M | -0.6 | -240.8 | -287.3 | -219.5 | 548.9 | 4 | BEARISH | -57.1 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| GDR.L Genedrive Plc | $20M | -1.1 | -707.4 | -3299.5 | -480.5 | 1299.0 | 6 | BEARISH | 54.8 |
| HVO.L hVIVO plc | $80M | -3.3 | -20.0 | -21.2 | -39.7 | -28.1 | 2 | BEARISH | -40.0 |
| CLBX.L CelLBxHealth plc | $10M | — | — | — | — | — | — | BEARISH | — |
| GENI.L GENinCode plc | — | -0.5 | -419.6 | -8421.9 | -223.9 | 27.8 | 4 | BEARISH | -46.4 |
| ABDX.L Abingdon Health Plc | $40M | -13.1 | -143.7 | -152.8 | -55.4 | 116.1 | 5 | NEUTRAL | 92.2 |
| VRCI.L Verici Dx plc | $10M | -0.6 | -240.8 | -287.3 | -219.5 | 548.9 | 4 | BEARISH | -57.1 |
| ANPCF Cellbxhealth PLC | $20M | — | -239.7 | -609.1 | -452.4 | -32.8 | 2 | BEARISH | -58.3 |
| GDR.L Genedrive Plc | $20M | -1.1 | -707.4 | -3299.5 | -480.5 | 1299.0 | 6 | BEARISH | 54.8 |
| HVO.L hVIVO plc | $80M | -3.3 | -20.0 | -21.2 | -39.7 | -28.1 | 2 | BEARISH | -40.0 |
| CLBX.L CelLBxHealth plc | $10M | — | — | — | — | — | — | BEARISH | — |
Profile Radar
Valuation vs Profitability
Performance Comparison
Industry Market Share
GENI.L vs Benchmarks
ROIC
Gross Margin
Op Margin
Net Margin
Revenue Growth
P/E Ratio
ROE
Piotroski F